Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ipsen
Podcast
Ipsen R&D chief on pipeline discipline and 2026 milestones
Christelle Huguet, Ph.D., Ipsen’s EVP and head of R&D, explains why she sees the biopharma as an “accelerator” of innovation.
Ayla Ellison
Jun 12, 2026 9:57am
Ipsen unveils data that drove anti-wrinkle jab into phase 3
May 18, 2026 5:06am
Ipsen scuttles liver disease candidates from Albireo acquisition
May 6, 2026 3:10pm
BioNTech founders to pioneer new company—Chutes & Ladders
Mar 13, 2026 8:30am
Ipsen fails to land pivotal rare disease trial
Dec 19, 2025 3:37pm
Ipsen inks €1B buyout of French biotech ImCheck
Oct 22, 2025 10:33am
